Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) CCL21 Antibodies:
anti-Human CCL21 Antibodies:
anti-Rat (Rattus) CCL21 Antibodies:
Go to our pre-filtered search.
Human Polyclonal CCL21 Primary Antibody for IF (p), IHC (p) - ABIN732698
Borrelli, Abrão, Taube, Darb-Esfahani, Köhler, Kaufmann, Chiantera, Mechsner: Immunohistochemical Investigation of Metastasis-Related Chemokines in Deep-Infiltrating Endometriosis and Compromised Pelvic Sentinel Lymph Nodes. in Reproductive sciences (Thousand Oaks, Calif.) 2015
Human Polyclonal CCL21 Primary Antibody for IHC, IHC (p) - ABIN4288804
Andersson, Nilsson, Fagerberg, Hallström, Sundström, Danielsson, Edlund, Uhlen, Asplund: The transcriptomic and proteomic landscapes of bone marrow and secondary lymphoid tissues. in PLoS ONE 2014
the CCR7 (show CCR7 Antibodies)/CCL21 signaling pathway leading to T lymphocyte migration on fibronectin (show FN1 Antibodies) is a beta1 integrin-dependent pathway involving transient ERK1/2 phosphorylation, which is modulated by PLCgamma1 (show PLCG1 Antibodies)
Data suggest that lymphotoxin (show LTB Antibodies)-dependent and -independent regulation of CC chemokine ligand 21-b and -c plays a role in balancing the central and peripheral immune responses between lymphoid and nonlymphoid tissues.
CCL21 and, to a lesser extent, CCL19 (show CCL19 Antibodies) play significant roles in the distinctive localization of marginal zone macrophages within the splenic marginal zone.
CCL21 and 5'-Nase may be involved in the interaction between infiltrating cells and lymphatic vessels to induce the functional changes of lymphatic endothelial cells during insulitic and diabetic development
CXCL9 (show CXCL9 Antibodies) has a role in graft rejection in the absence of CCL19 (show CCL19 Antibodies) and CCL21
T-cell defects in the nasal-associated lymphoid tissue of lymphotoxin (show LTB Antibodies)(-/-) mice can be attributed to the impaired expression of CCL21.
alpha-GalCer-loaded dendritic cells expressing tumor-associated antigen along with SLC (show CCL21A Antibodies) can stimulate multiple subsets of effector cells to induce a potent therapeutic effect against peritoneally disseminated tumor cells.
following Leishmania donovani infection of mice, the migration of splenic DC is regulated by the CCR7 (show CCR7 Antibodies) ligands CCL19 (show CCL19 Antibodies)/CCL21
Results suggest that CCR7 (show CCR7 Antibodies)-positive fibrocytes infiltrate the kidney via CCL21-positive vessels, thereby contributing to the pathogenesis of renal fibrosis.
The presence of CCL21 during the in vitro stimulation of CD4 (show CD4 Antibodies)+ T cells with anti-CD3 (show CD3E Antibodies) plus anti-CD28 (show CD28 Antibodies) significantly enhanced in vitro AICD induction of the restimulated T cells, partially through enhancing expression of Fas ligand (show FASL Antibodies).
High CCL21 expression is associated with urinary bladder cancer metastasis.
Significant associations between the CCL21 rs2812378 G;A polymorphism and rheumatoid arthritis risk were observed in the total population, as well as in subgroup Caucasian population.
The research findings demonstrate for the first time that the chemokines CCL19 (show CCL19 Antibodies), CCL21 and CCR7 (show CCR7 Antibodies) play important roles in bone destruction by increasing osteoclast migration and resorption activity, and that has been linked to rheumatoid arthritis pathogenesis.
Low CCL21 expression was a potential independent adverse prognostic biomarker for overall survival and progression-free survival for metastatic renal cell carcinoma (show MOK Antibodies) patients treated with targeted therapy.
The migratory index to the CCR7 (show CCR7 Antibodies) ligands, CCL19 (show CCL19 Antibodies) and CCL21, was higher in T-cells from donors whose recipients will develop GvHD.
these results demonstrated that CCL21/CCR7 may activate EMT in lung cancer cells via the ERK1/2 signaling pathway.
CCL21/CCR7 (show CCR7 Antibodies) interaction was shown to allow NK cell adhesion to endothelial cells (ECs) and its reduction by hypoxia.
These data show that CCR7 (show CCR7 Antibodies)-CCL19 (show CCL19 Antibodies)/CCL21 axis facilitates retention CD4 (show CD4 Antibodies)(+) T lymphocytes at the site of collateral artery remodeling, which is essential for effective arteriogenesis.
CCL21 correlated significantly with Bladder Pain Syndrome: gene expression in bladder biopsies of patients with Bladder Pain Syndrome was increased in the patients and correlated with clinical profiles.
CCL21/IL21 (show IL17C Antibodies)-armed oncolytic adenovirus enhances antitumor activity against TERT (show TERT Antibodies)-positive tumor cells.
This gene is one of several CC cytokine genes clustered on the p-arm of chromosome 9. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. Similar to other chemokines the protein encoded by this gene inhibits hemopoiesis and stimulates chemotaxis. This protein is chemotactic in vitro for thymocytes and activated T cells, but not for B cells, macrophages, or neutrophils. The cytokine encoded by this gene may also play a role in mediating homing of lymphocytes to secondary lymphoid organs. It is a high affinity functional ligand for chemokine receptor 7 (CCR7) that is expressed on T and B lymphocytes and a known receptor for another member of the cytokine family (small inducible cytokine A19).
C-C motif chemokine 21b
, C-C motif chemokine 21c
, Small-inducible cytokine A21b
, beta chemokine exodus-2
, beta-chemokine exodus-2
, small inducible cytokine A21c
, small-inducible cytokine A21c
, thymus-derived chemotactic agent 4
, C-C motif chemokine 21
, Efficient Chemoattractant for Lymphocytes
, secondary lymphoid tissue chemokine
, small inducible cytokine subfamily A (Cys-Cys), member 21
, CC chemokine ligand 21
, putative CCL21 chemokine
, chemokine CCL21/6CKINE
, small-inducible cytokine A21
, small inducible cytokine A21
, chemokine (C-C motif) ligand 21
, chemokine (C-C motif) ligand 21b (serine)